GLAM
TSVT

Gardner Lewis Asset Management’s 2seventy bio TSVT Stock Holding History

Gardner Lewis Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-395,936
Closed -$1.96M – 88
2025
Q1 		$1.96M Buy
+395,936
New +$1.26M 0.47% 49

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gardner Lewis Asset Management's TSVT Position: Q2 2025 in Review

Gardner Lewis Asset Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 395,936 shares — an estimated $1.96M sold.

Gardner Lewis Asset Management first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $1.96M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Gardner Lewis Asset Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 395,936 2seventy bio shares in Q2 2025, an estimated $1.96M.
  • Gardner Lewis Asset Management first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
  • Gardner Lewis Asset Management's 2seventy bio position peaked at $1.96M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.